A Phase II Study of Cetuximab (C225) in Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): An Interim Overall Toxicity Report of the RTOG 0324 Trial

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 63; p. S44
Main Authors Komaki, R., Swann, S., Curran, W., Robert, F., Maria, W., Lee, C., Jafar, S., Share, R., Choy, H., Blumenschein, G.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2005
Online AccessGet full text

Cover

More Information
ISSN:0360-3016
1879-355X
DOI:10.1016/j.ijrobp.2005.07.078